SIBN Logo

SI-BONE, Inc. (SIBN) 

NASDAQ
Market Cap
$517.31M
Sector
Healthcare
Industry
Medical—Devices
Rank in Sector
710 of 774
Rank in Industry
90 of 99

Largest Insider Buys in Sector

SIBN Stock Price History Chart

SIBN Stock Performance

About SI-BONE, Inc.

SI-BONE, Inc., a medical device company, develops implantable devices used to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers iFuse, a minimally invasive surgical implant system to address sacroiliac joint dysfunction and degeneration, adult deformity, and pelvic ring traumatic fractures. The company also provides iFuse-3D, a titanium implant that combines the triangular cross-section of the iFuse implant with the proprietary 3D-printed porous surface and fenestrated design; and …

Insider Activity of SI-BONE, Inc.

Over the last 12 months, insiders at SI-BONE, Inc. have bought $0 and sold $2.62M worth of SI-BONE, Inc. stock.

On average, over the past 5 years, insiders at SI-BONE, Inc. have bought $0 and sold $20.23M worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 400,000 shares for transaction amount of $6M was made by Bonita David P (director) on 2018‑10‑19.

List of Insider Buy and Sell Transactions, SI-BONE, Inc.

2024-11-19SalePresident, Commercial Ops
2,070
0.0049%
$12.17$25,1950.00%
2024-11-18SaleChief Executive Officer
10,048
0.0244%
$12.57$126,3540.00%
2024-11-18SalePresident, Commercial Ops
3,937
0.0096%
$12.60$49,6090.00%
2024-11-18SaleChief Financial Officer
2,439
0.006%
$12.68$30,9370.00%
2024-11-18Saledirector
1,609
0.0039%
$12.43$20,0010.00%
2024-11-04Saledirector
341
0.0008%
$13.55$4,621+13.32%
2024-10-03SalePresident, Commercial Ops
921
0.0022%
$13.60$12,526-4.55%
2024-10-02SalePresident, Commercial Ops
3,305
0.0078%
$13.58$44,877-2.72%
2024-10-02SaleChief Financial Officer
3,305
0.0078%
$13.58$44,886-2.72%
2024-09-03SaleChief Financial Officer
1,414
0.0035%
$16.35$23,119-13.43%
2024-08-19SalePresident, Commercial Ops
2,087
0.005%
$14.17$29,569+3.70%
2024-08-16SaleChief Executive Officer
9,967
0.0235%
$13.84$137,970-0.49%
2024-08-16SalePresident, Commercial Ops
3,905
0.0092%
$13.84$54,037-0.49%
2024-08-16SaleChief Financial Officer
2,418
0.0057%
$13.87$33,538-0.49%
2024-08-16Saledirector
1,580
0.0037%
$13.84$21,867-0.49%
2024-08-02Saledirector
343
0.0008%
$14.32$4,912-3.56%
2024-07-03SalePresident, Commercial Ops
920
0.0023%
$13.05$12,0070.00%
2024-07-02SalePresident, Commercial Ops
3,309
0.0083%
$12.92$42,7550.00%
2024-07-02SaleChief Financial Officer
3,309
0.0083%
$12.90$42,6940.00%
2024-06-10Saledirector
341
0.0008%
$12.99$4,430+8.14%

Insider Historical Profitability

<0.0001%
Skyline Venture Partners V LP10 percent owner
2819985
6.7241%
$12.3417<0.0001%
Petersen Timothydirector
1695036
4.0417%
$12.3410<0.0001%
ORBIMED ADVISORS LLCdirector
985368
2.3496%
$12.3410<0.0001%
Bonita David Pdirector
985368
2.3496%
$12.3410<0.0001%
Freund John Gordondirector
103899
0.2477%
$12.34123<0.0001%

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Brown Advisory$69.14M10.254.22M+0.37%+$256,010.450.09
BlackRock$64.22M9.523.92M+0.41%+$261,314.31<0.01
OrbiMed$51.97M7.73.17M+38.47%+$14.44M0.4
First Light Asset Management$40.49M62.47M-2.91%-$1.22M3.41
The Vanguard Group$40.33M5.982.46M+1.8%+$714,877.89<0.01
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.